Driving Pediatric And Neonatal Testing Kit Market Growth in 2025: The Role of Growing Prevalence Of Congenital Disorders Fuels Expansion Of Pediatric And Neonatal Testing Kit Market

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

Pediatric And Neonatal Testing Kit Market Size Growth Forecast: What to Expect by 2025?
The market for pediatric and neonatal testing kits has seen substantial growth in recent years, expanding from $3.91 billion in 2024 to predicting a rise to $4.18 billion in 2025 with a compound annual growth rate (CAGR) of 6.7%. The growth observed in the past can be accredited to advances in pediatric and neonatal care, augmented focus on child health, development in healthcare facilities, increased awareness about prenatal testing, and changes in the regulatory environment.

How Will the Pediatric And Neonatal Testing Kit Market Size Evolve and Grow by 2029?
In the coming years, robust growth is projected for the pediatric and neonatal testing kit market, with the market size set to magnify to $5.98 billion by 2029, recording a compound annual growth rate (CAGR) of 9.4%. Factors influencing growth during the forecast period involve increasing consumer preference for non-invasive tests, the broadening scope of point-of-care testing in the pediatric segment, escalated funding in neonatal and pediatric studies, and the assimilation of digital health technology. Key trends for this period encompass the production of swift and precise testing kits, the use of next-generation sequencing in child diagnostics, reinforcement of newborn screening initiatives, a heightened emphasis on metabolic testing in newborns, and the incorporation of artificial intelligence in diagnostic apparatus.

View the full report here:
https://www.thebusinessresearchcompany.com/report/pediatric-and-neonatal-testing-kit-global-market-report

What Drivers Are Propelling the Growth of Pediatric And Neonatal Testing Kit Market Forward?
The rising incidence of congenital abnormalities in new-born babies is propelling the growth of the pediatric and neonatal testing kit market. These congenital disorders occur during fetal development or can be present at the time of birth. Screening for pediatric and neonatal conditions is crucial as it enables the detection of any congenital impairments, allowing healthcare professionals to initiate early treatment. For example, as reported by the World Health Organization (WHO), a specialized health arm of the United Nations based in Switzerland, around 240,000 babies globally succumb within their first 28 days of existence every year due to congenital disorders. Further, congenital conditions claim approximately 170,000 lives of children aged between 1 month and 5 years. It is this escalating prevalence of congenital disorders that fuels the demand for pediatric and neonatal testing kits.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12198&type=smp

What Trends Will Shape the Pediatric And Neonatal Testing Kit Market Through 2029 and Beyond?
The trend of creating innovative screening tests is witnessing growing traction in the pediatric and neonatal testing kits market. Leading market players are concentrating their efforts on devising new screening kits such as mass screening tests, as part of their strategy to retain their market standing. For example, in May 2024, Shimadzu Techno-Research, Inc., a Japanese contract analysis firm, rolled out a fresh contract service for conducting PCR tests aimed at comprehensive neonatal mass screening. This service covers testing for critical rare diseases such as Severe Combined Immunodeficiency (SCID), B-cell Deficiency (BCD), and Spinal Muscular Atrophy (SMA), with the goal to discern these diseases soon after birth to facilitate immediate intervention and treatment, thereby improving health outcomes for neonates. Currently, 40 out of the total 47 prefectures in Japan have access to this service, with measures in progress to make this service available to all newborns through public financing. By teaming up with hospitals and childbirth facilities, STR is committed to enhancing the health and wellbeing of neonates across Japan.

What Are the Key Segments in the Pediatric And Neonatal Testing Kit Market?
The pediatric and neonatal testing kit market covered in this report is segmented -

1) By Test Type: Dried Blood Spot, Hearing Screening, Critical Congenital Heart Defect (CCHD), Other Test Types
2) By Product: Assay Kits And Reagents, Instruments
3) By Technology: Tandem Mass Spectrometry, Pulse Oximetry, Enzyme-Based Assays, DNA Based Assays, Electrophoresis, Others Technologies
4) By End User: Hospitals, Diagnostic Centers, Maternity And Specialty Clinics, Other End Users

Subsegments:
1) By Dried Blood Spot: Newborn Screening Panels, Genetic Testing, Infectious Disease Screening
2) By Hearing Screening: Automated Auditory Brainstem Response (ABR) Tests, Otoacoustic Emissions (OAE) Tests, Portable Hearing Screening Devices
3) By Critical Congenital Heart Defect (CCHD): Pulse Oximetry Screening Kits, Echocardiography Screening Tools, Clinical Assessment Protocols
4) By Other Test Types: Blood Gas Analysis Kits, Urine Testing Kits, Infectious Disease Testing, Point-of-Care Testing Devices

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=12198&type=smp

Who Are the Key Players Shaping the Pediatric And Neonatal Testing Kit Market's Competitive Landscape?
Major companies operating in the pediatric and neonatal testing kit market include F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Medtronic Plc, Siemens Healthineers, GE Healthcare GmbH, Eurofins Scientific SE, Trivitron Healthcare Pvt Ltd., Hologic Inc., PerkinElmer Inc., Quidel Corporation, Bio-Rad Laboratories Inc., QIAGEN NV, Natus Medical Incorporated, BioFire Diagnostics LLC, Luminex Corporation, Meridian Bioscience Inc., MP Biomedicals LLC, ELITech Group SAS, Baebies Inc., Labsystems Diagnostics Oy, Advacare Pharma LLP, Beckman Coulter Inc., JETA Molecular BV, EpigenTek Group Inc., ZenTech SA, Hangzhou Testsea Biotechnology Co. Ltd.

What Geographic Markets Are Powering Growth in the Pediatric And Neonatal Testing Kit Market?
North America was the largest region in the pediatric and neonatal testing kit market in 2024. The regions covered in the pediatric and neonatal testing kit market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12198

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Saumya Sahey
Europe: +44 7882 955267,
Asia: +44 7882 955267 & +91 8897263534,
Americas: +1 310-496-7795
Email: saumyas@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.